Cetera Investment Advisers’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$121M Buy
345,260
+2,800
+0.8% +$998K 0.13% 143
2025
Q4
$112M Buy
342,460
+16,913
+5% +$5.36M 0.12% 149
2025
Q3
$91.9M Buy
325,547
+102,251
+46% +$29.7M 0.11% 176
2025
Q2
$62.3M Sell
223,296
-2,923
-1% -$828K 0.11% 185
2025
Q1
$70.5M Buy
226,219
+26,309
+13% +$7.77M 0.14% 149
2024
Q4
$52.1M Buy
199,910
+11
+0% +$3.26K 0.11% 187
2024
Q3
$64.4M Sell
199,899
-2,849
-1% -$932K 0.14% 146
2024
Q2
$63.3M Sell
202,748
-30,631
-13% -$9M 0.15% 136
2024
Q1
$66.4M Buy
233,379
+170,108
+269% +$49.8M 0.16% 126
2023
Q4
$18.2M Sell
63,271
-934
-1% -$254K 0.15% 133
2023
Q3
$17.3M Buy
64,205
+3,146
+5% +$785K 0.15% 135
2023
Q2
$13.6M Buy
61,059
+4,862
+9% +$1.13M 0.11% 160
2023
Q1
$13.6M Buy
56,197
+3,039
+6% +$746K 0.12% 155
2022
Q4
$14M Sell
53,158
-21,776
-29% -$5.84M 0.13% 155
2022
Q3
$17K Buy
74,934
+30,228
+68% +$7.33M ﹤0.01% 1643
2022
Q2
$10.9M Buy
44,706
+2,142
+5% +$525K 0.17% 121
2022
Q1
$10.3M Buy
42,564
+3,735
+10% +$858K 0.15% 141
2021
Q4
$8.73M Buy
38,829
+1,602
+4% +$338K 0.13% 174
2021
Q3
$7.92M Sell
37,227
-2,881
-7% -$663K 0.13% 182
2021
Q2
$9.78M Buy
40,108
+10,819
+37% +$2.66M 0.16% 148
2021
Q1
$7.29M Sell
29,289
-6,781
-19% -$1.62M 0.14% 153
2020
Q4
$8.29M Buy
36,070
+33,811
+1,497% +$7.8M 0.16% 139
2020
Q3
$574K Sell
2,259
-39
-2% -$9.66K 0.05% 349
2020
Q2
$542K Sell
2,298
-46
-2% -$10.5K 0.05% 339
2020
Q1
$475K Sell
2,344
-32
-1% -$6.99K 0.06% 312
2019
Q4
$572K Buy
2,376
+438
+23% +$96.5K 0.06% 315
2019
Q3
$378K Buy
1,938
+305
+19% +$58.5K 0.05% 358
2019
Q2
$302K Buy
1,633
+154
+10% +$27.6K 0.04% 383
2019
Q1
$282K Sell
1,479
-2,211
-60% -$422K 0.04% 383
2018
Q4
$720K Sell
3,690
-369
-9% -$72K 0.12% 190
2018
Q3
$838K Buy
4,059
+1,381
+52% +$272K 0.12% 187
2018
Q2
$493K Sell
2,678
-150
-5% -$26.5K 0.09% 243
2018
Q1
$482K Sell
2,828
-849
-23% -$156K 0.09% 232
2017
Q4
$637K Buy
3,677
+213
+6% +$37.7K 0.12% 206
2017
Q3
$650K Buy
3,464
+386
+13% +$68.4K 0.14% 188
2017
Q2
$529K Buy
3,078
+511
+20% +$83.1K 0.13% 206
2017
Q1
$423K Buy
2,567
+172
+7% +$28.6K 0.12% 224
2016
Q4
$349K Buy
2,395
+874
+57% +$132K 0.12% 223
2016
Q3
$254K Sell
1,521
-3,479
-70% -$588K 0.11% 217
2016
Q2
$759K Buy
5,000
+366
+8% +$56.9K 0.3% 106
2016
Q1
$694K Buy
4,634
+156
+3% +$23.2K 0.3% 100
2015
Q4
$724K Buy
+4,478
New +$704K 0.33% 91

Other funds holding AMGN

Cetera Investment Advisers's AMGN Position: Q1 2026 in Review

Cetera Investment Advisers increased its Amgen (AMGN) stake by 0.82% in Q1 2026, buying an estimated $998K and bringing the position to 345,260 shares worth $121M. The position accounts for 0.13% of the portfolio, ranked #143.

Cetera Investment Advisers first reported a position in AMGN in Q4 2015 and has held it in 42 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Cetera Investment Advisers held 345,260 shares of Amgen worth $121M as of Q1 2026.
  • Cetera Investment Advisers bought 2,800 Amgen shares in Q1 2026, an estimated $998K.
  • Amgen made up 0.13% of Cetera Investment Advisers's portfolio in Q1 2026, its #143 holding.
  • Cetera Investment Advisers first reported a position in Amgen in Q4 2015 and has held it in 42 quarters since.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.